{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["11"],"submitter":["Huebner H"],"pubmed_abstract":["<h4>Background</h4>The introduction of oral anticancer therapies has, at least partially, shifted treatment from clinician-supervised hospital care to patient-managed home regimens. However, patients with breast cancer receiving oral cyclin-dependent kinase 4/6 inhibitor therapy still require regular hospital visits to monitor side effects. Telemonitoring has the potential to reduce hospital visits while maintaining quality care.<h4>Objective</h4>This study aims to develop a digital home-based health care center (DHHC) for acquiring electrocardiograms (ECGs), white blood cell (WBC) counts, side effect photo documentation, and patient-reported quality of life (QoL) data.<h4>Methods</h4>The DHHC was set up using an Apple Watch Series 6 (ECG measurements), a HemoCue WBC DIFF Analyzer (WBC cou"],"journal":["JMIR cancer"],"pagination":["e64083"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12064077"],"repository":["biostudies-literature"],"pubmed_title":["A Digital Home-Based Health Care Center for Remote Monitoring of Side Effects During Breast Cancer Therapy: Prospective, Single-Arm, Monocentric Feasibility Study."],"pmcid":["PMC12064077"],"pubmed_authors":["Limpert M","Kreis P","Heindl F","Volz B","Mocker A","Roth E","Ruebner M","Wurmthaler LA","Fasching PA","Huebner H","Kruckel A","Kallert M","Uhrig S","Horner M","Seitz K","Ernst M","Geck J","Hack CC","Beckmann MW","Goossens C"],"additional_accession":[]},"is_claimable":false,"name":"A Digital Home-Based Health Care Center for Remote Monitoring of Side Effects During Breast Cancer Therapy: Prospective, Single-Arm, Monocentric Feasibility Study.","description":"<h4>Background</h4>The introduction of oral anticancer therapies has, at least partially, shifted treatment from clinician-supervised hospital care to patient-managed home regimens. However, patients with breast cancer receiving oral cyclin-dependent kinase 4/6 inhibitor therapy still require regular hospital visits to monitor side effects. Telemonitoring has the potential to reduce hospital visits while maintaining quality care.<h4>Objective</h4>This study aims to develop a digital home-based health care center (DHHC) for acquiring electrocardiograms (ECGs), white blood cell (WBC) counts, side effect photo documentation, and patient-reported quality of life (QoL) data.<h4>Methods</h4>The DHHC was set up using an Apple Watch Series 6 (ECG measurements), a HemoCue WBC DIFF Analyzer (WBC cou","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 May","modification":"2026-03-13T10:32:11.807Z","creation":"2025-08-13T03:04:20.81Z"},"accession":"S-EPMC12064077","cross_references":{"pubmed":["40315425"],"doi":["10.2196/64083"]}}